Impaired expansion of mouse B cell progenitors lacking Btk.

[1]  A. Satterthwaite,et al.  Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain. , 1995, Immunity.

[2]  M. Barbacid,et al.  Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+CDS+thymocytes , 1995, Nature.

[3]  F. Alt,et al.  Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene , 1995, Nature.

[4]  K. Rajewsky,et al.  Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav , 1995, Nature.

[5]  Wei Wei Wu,et al.  CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction. , 1995, International immunology.

[6]  R. Perlmutter,et al.  Control of lymphopoiesis by p50csk, a regulatory protein tyrosine kinase , 1995, The Journal of experimental medicine.

[7]  M. Qi,et al.  Derivation of novel embryonic stem cell lines and targeting of cyclic AMP-dependent protein kinase genes. , 1995, Recent progress in hormone research.

[8]  J. D. Thomas,et al.  Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci. , 1994, Journal of immunology.

[9]  C. Larsson,et al.  BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. , 1994, Oncogene.

[10]  R J Armitage,et al.  Humoral immune responses in CD40 ligand-deficient mice , 1994, The Journal of experimental medicine.

[11]  K. Isselbacher,et al.  Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Sigler,et al.  Crystal structure at 2.2 Å resolution of the pleckstrin homology domain from human dynamin , 1994, Cell.

[13]  G. Litman,et al.  Atypical X-linked agammaglobulinemia. , 1994, The New England journal of medicine.

[14]  R. Hendriks,et al.  B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia. , 1994, The Journal of biological chemistry.

[15]  J. Fargnoli,et al.  Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. Kawakami,et al.  The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Nelson,et al.  Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Hajduk,et al.  Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate , 1994, Nature.

[19]  O. Witte,et al.  Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking , 1994, Molecular and cellular biology.

[20]  Michael Nilges,et al.  Structure of the pleckstrin homology domain from β-spectrin , 1994, Nature.

[21]  P. Hajduk,et al.  Solution structure of a pleckstrin-homology domain , 1994, Nature.

[22]  S. Amselem,et al.  An exon‐skipping mutation in thebtk gene of a patient with X‐linked agammaglobulinemia and isolated growth hormone deficiency , 1994, FEBS letters.

[23]  Y. Ohta,et al.  TXK, a novel human tyrosine kinase expressed in T cells shares sequence identity with Tec family kinases and maps to 4p12. , 1994, Human molecular genetics.

[24]  F. Alt,et al.  The expression of Vpre-B/λ5 surrogate light chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice , 1994, Cell.

[25]  R. Lefkowitz,et al.  Binding of G protein beta gamma-subunits to pleckstrin homology domains. , 1994, The Journal of biological chemistry.

[26]  V. Stewart,et al.  Generation of normal T and B lymphocytes by c-jun deficient embryonic stem cells. , 1994, Immunity.

[27]  D. Campana,et al.  X‐Linked Agammaglobulinemia: New Approaches to Old Questions based on the Identification of the Defective Gene , 1994, Immunological reviews.

[28]  I. Vořechovský,et al.  X‐Linked Agammaglobulinemia and Other Immunoglobulin Deficiencies , 1994, Immunological reviews.

[29]  O. Witte,et al.  Bruton's Tyrosine Kinase is a Key Regulator in B‐Cell Development , 1994, Immunological reviews.

[30]  John D Lambris,et al.  Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. , 1994, Journal of immunology.

[31]  G. Klaus,et al.  B cells from CBA/N mice do not proliferate following ligation of CD40 , 1994, European journal of immunology.

[32]  T. Winkler,et al.  Roles of IgH and L chains and of surrogate H and L chains in the development of cells of the B lymphocyte lineage. , 1994, Annual review of immunology.

[33]  R. Hendriks,et al.  Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice. , 1994, Human molecular genetics.

[34]  R. Lovering,et al.  Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis. , 1994, Human molecular genetics.

[35]  J. V. van Dongen,et al.  The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages , 1993, European journal of immunology.

[36]  S. Malek,et al.  SH2 domains of the protein-tyrosine kinases Blk, Lyn, and Fyn(T) bind distinct sets of phosphoproteins from B lymphocytes. , 1993, The Journal of biological chemistry.

[37]  N. Harada,et al.  Expression cloning of a cDNA encoding a novel murine B cell activation marker. Homology to human CD38. , 1993, Journal of immunology.

[38]  G. Shaw.  Identification of novel pleckstrin homology (PH) domains provides a hypothesis for PH domain function. , 1993, Biochemical and biophysical research communications.

[39]  H. Nakauchi,et al.  IL-5 receptor positive B cells, but not eosinophils, are functionally and numerically influenced in mice carrying the X-linked immune defect. , 1993, International immunology.

[40]  J. Thompson,et al.  The PH domain: a common piece in the structural patchwork of signalling proteins. , 1993, Trends in biochemical sciences.

[41]  R. Hardy,et al.  The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver , 1993, The Journal of experimental medicine.

[42]  J. Bolen.  Nonreceptor tyrosine protein kinases. , 1993, Oncogene.

[43]  D J Rawlings,et al.  Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. , 1993, Science.

[44]  W. Paul,et al.  Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. , 1993, Science.

[45]  V. Stewart,et al.  RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[46]  T. Kawakami,et al.  Structure and expression of novel protein-tyrosine kinases, Emb and Emt, in hematopoietic cells. , 1993, Biochemical and biophysical research communications.

[47]  P Cicchetti,et al.  Identification of a ten-amino acid proline-rich SH3 binding site. , 1993, Science.

[48]  N. Copeland,et al.  Expression of a novel form of Tec kinase in hematopoietic cells and mapping of the gene to chromosome 5 near Kit. , 1993, Oncogene.

[49]  Ornella Parolini,et al.  Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia , 1993, Cell.

[50]  D. Bentley,et al.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases , 1993, Nature.

[51]  R. Perlmutter,et al.  Regulation of lymphocyte function by protein phosphorylation. , 1993, Annual review of immunology.

[52]  S. Desiderio,et al.  itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[53]  T. Pawson,et al.  SH2 and SH3 domains: From structure to function , 1992, Cell.

[54]  R. Perlmutter,et al.  Defective T cell receptor signaling in mice lacking the thymic isoform of p59 fyn , 1992, Cell.

[55]  D. Baltimore,et al.  Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. , 1992, Science.

[56]  C. S. Scott,et al.  Abnormal CD45R expression in patients with common variable immunodeficiency and X‐linked agammaglobulinaemia , 1992, British journal of haematology.

[57]  D. Mccluskey,et al.  CD4 lymphocyte subset abnormalities associated with impaired delayed cutaneous hypersensitivity reactions in patients with X‐linked agammaglobulinaemia , 1992, Clinical and experimental immunology.

[58]  N. Rosenberg,et al.  The Ig VH repertoire of fetal liver-derived pre-B cells is influenced by the expression of a gene linked to X-linked immune deficiency. , 1992, Journal of immunology.

[59]  V. Stewart,et al.  RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.

[60]  T Pawson,et al.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.

[61]  J D Kemp,et al.  Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow , 1991, The Journal of experimental medicine.

[62]  K. M. Abraham,et al.  Regulation of T cell receptor signaling by a src family protein-tyrosine kinase (p59 fyn ) , 1991, Cell.

[63]  D. Baltimore,et al.  The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[64]  S. Pillai,et al.  The omega/lambda 5 surrogate immunoglobulin light chain is expressed on the surface of transitional B lymphocytes in murine bone marrow , 1991, The Journal of experimental medicine.

[65]  D. G. Osmond,et al.  Proliferation kinetics and the lifespan of B cells in central and peripheral lymphoid organs. , 1991, Current opinion in immunology.

[66]  T. Mosmann,et al.  Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells , 1990, The Journal of experimental medicine.

[67]  D. Campana,et al.  Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. , 1990, Journal of immunology.

[68]  D. Schatz,et al.  RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. , 1990, Science.

[69]  David Baltimore,et al.  The V(D)J recombination activating gene, RAG-1 , 1989, Cell.

[70]  R. Hardy,et al.  Analysis of lymphoid population in scid mice; detection of a potential B lymphocyte progenitor population present at normal levels in scid mice by three color flow cytometry with B220 and S7. , 1989, Current topics in microbiology and immunology.

[71]  K. Kammermeyer,et al.  Primary sequence and developmental expression of a novel Drosophila melanogaster src gene , 1987, Molecular and cellular biology.

[72]  L. Forrester,et al.  Development of B lymphocytes in mice heterozygous for the X-linked immunodeficiency (xid) mutation. xid inhibits development of all splenic and lymph node B cells at a stage subsequent to their initial formation in bone marrow , 1987, The Journal of experimental medicine.

[73]  R. Kaufman,et al.  Translational efficiency of polycistronic mRNAs and their utilization to express heterologous genes in mammalian cells. , 1987, The EMBO journal.

[74]  E. Robertson.  Teratocarcinomas and embryonic stem cells : a practical approach , 1987 .

[75]  D. G. Osmond,et al.  Population Dynamics of Bone Marrow B Lymphocytes , 1986, Immunological reviews.

[76]  L. Wicker,et al.  X-linked immune deficiency (xid) of CBA/N mice. , 1986, Current topics in microbiology and immunology.

[77]  N. Rosenberg,et al.  Early arrest of B cell development in nude, X‐linked immune‐deficient mice , 1986, European journal of immunology.

[78]  G. Reid,et al.  B lymphocyte production in the bone marrow of mice with X-linked immunodeficiency (xid). , 1985, Journal of immunology.

[79]  M. Cooper,et al.  Evaluation of lymphocyte differentiation in primary and secondary immunodeficiency diseases. , 1985, Journal of immunology.

[80]  M. Conley.  B cells in patients with X-linked agammaglobulinemia. , 1985, Journal of immunology.

[81]  J. Sprent,et al.  Physiology of B cells in mice with X-linked immunodeficiency. I. Size, migratory properties, and turnover of the B cell pool. , 1985, Journal of immunology.

[82]  J. Sprent,et al.  Physiology of B cells in mice with X-linked immunodeficiency (xid). III. Disappearance of xid B cells in double bone marrow chimeras , 1984, The Journal of experimental medicine.

[83]  J. Paslay,et al.  Unbalanced X chromosome mosaicism in B cells of mice with X-linked immunodeficiency , 1983, The Journal of experimental medicine.

[84]  P. Kincade,et al.  B‐Lymphocyte Precursors in Immunodeficient, Autoimmune and Anemic Mice , 1982, Immunological reviews.

[85]  W. Paul,et al.  Role of the thymus in directing the development of a subset of B lymphocytes , 1982, The Journal of experimental medicine.

[86]  L. Burkly,et al.  Lack of mature B cells in nude mice with X-linked immune deficiency , 1982, The Journal of experimental medicine.

[87]  I. Scher,et al.  The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity. , 1982, Advances in immunology.

[88]  L. Lanier,et al.  Quantitative immunofluorescent analysis of surface phenotypes of murine B cell lymphomas and plasmacytomas with monoclonal antibodies. , 1981, Journal of immunology.

[89]  B. Fowlkes,et al.  Ly 9, an alloantigenic marker of lymphocyte differentiation. , 1980, Journal of immunology.

[90]  R. Perlmutter,et al.  Immunoglobulin subclass-specific immunodeficiency in mice with an X- linked B-lymphocyte defect , 1979, The Journal of experimental medicine.

[91]  W. Paul,et al.  Activation of mouse lymphocytes by anti-immunoglobulin. II. A thymus- independent response by a mature subset of B lymphocytes , 1978, The Journal of experimental medicine.

[92]  M. Cooper,et al.  B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody-deficiency states. , 1978, Journal of immunology.

[93]  A. Ahmed,et al.  X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells , 1975, The Journal of experimental medicine.

[94]  A. Steinberg,et al.  The genetics of the immune response to a synthetic double-stranded RNA in a mutant CBA mouse strain. , 1973, Journal of immunology.

[95]  P. Baker,et al.  GENETIC CONTROL OF THE ANTIBODY RESPONSE TO TYPE III PNEUMOCOCCAL POLYSACCHARIDE IN MICE , 1972, The Journal of experimental medicine.

[96]  M. Cooper,et al.  Agammaglobulinaemia with B lymphocytes. Specific defect of plasma-cell differentiation. , 1971, Lancet.